These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 2239877)
1. Recurrence of duodenal ulcer and elevated serum pepsinogen I levels in smokers and nonsmokers. Sumii K; Kimura M; Morikawa A; Haruma K; Yoshihara M; Kajiyama G Am J Gastroenterol; 1990 Nov; 85(11):1493-7. PubMed ID: 2239877 [TBL] [Abstract][Full Text] [Related]
2. [Smoking and serum gastrin and pepsinogen I levels in patients with duodenal ulcers]. Lanas A; Miguel G; Escolar F; Sainz R; Abos D Rev Esp Enferm Dig; 1990 Jun; 77(6):397-402. PubMed ID: 2223248 [TBL] [Abstract][Full Text] [Related]
3. Serum group I pepsinogens by radioimmunoassay in control subjects and patients with peptic ulcer. Samloff IM; Liebman WM; Panitch NM Gastroenterology; 1975 Jul; 69(1):83-90. PubMed ID: 1150038 [TBL] [Abstract][Full Text] [Related]
4. [Serum pepsinogen I levels in bleeding duodenal ulcer]. Kolster JJ; Castro de Kolster C; Macía de Luco M G E N; 1990; 44(2):118-24. PubMed ID: 2152265 [TBL] [Abstract][Full Text] [Related]
5. [Levels of blood pepsinogen I in the offspring of patients with duodenal ulcer]. Kolster J; Castro de Kolster C; Castro J; Carvajal A; Callegari C G E N; 1991; 45(3):156-62. PubMed ID: 1843947 [TBL] [Abstract][Full Text] [Related]
6. Recurrence of duodenal ulcer under continuous antisecretory treatment: an approach to the detection of predictive markers. Battaglia G; Farini R; Di Mario F; Piccoli A; Plebani M; Vianello F; Burlina A; Naccarato R Am J Gastroenterol; 1984 Nov; 79(11):831-4. PubMed ID: 6095649 [TBL] [Abstract][Full Text] [Related]
7. [Cigarette smoking and group I pepsinogen levels. Study in a normal population]. Germanà B; Di Mario F; Vianello F; Dotto P; Faggian D; Plebani M; Saggioro A; Naccarato R G Clin Med; 1990; 71(8-9):493-5. PubMed ID: 2279624 [TBL] [Abstract][Full Text] [Related]
8. Does smoking predispose to peptic ulcer relapse after eradication of Helicobacter pylori? Chan FK; Sung JJ; Lee YT; Leung WK; Chan LY; Yung MY; Chung SC Am J Gastroenterol; 1997 Mar; 92(3):442-5. PubMed ID: 9068465 [TBL] [Abstract][Full Text] [Related]
9. Serum group I pepsinogen levels and their relation to gastric acid secretion in patients with and without recurrent ulcer. Samloff IM; Secrist DM; Passaro E Gastroenterology; 1976 Mar; 70(3):309-13. PubMed ID: 1248696 [TBL] [Abstract][Full Text] [Related]
10. Additive deleterious effect of smoking on gastroduodenal pathology and clinical course in Helicobacter pylori-positive dyspeptic patients. Moshkowitz M; Brill S; Konikoff FM; Averbuch M; Arber N; Halpern Z Isr Med Assoc J; 2000 Dec; 2(12):892-5. PubMed ID: 11344768 [TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of the measurement of serum pepsinogen group I and II by enzyme-linked immunosorbent assay]. Matsumoto K; Hashimoto K; Samori T; Taniguchi M; Kotera K; Nishi S; Takatsuji M; Higashi K; Itoh K Rinsho Byori; 1992 Sep; 40(9):977-81. PubMed ID: 1434035 [TBL] [Abstract][Full Text] [Related]
13. The effect of betazole on serum group I pepsinogen levels: studies in symptomatic patients with and without recurrent ulcer after vagotomy and gastric resection or drainage. Samloff IM; Secrist DM; Passaro E Gastroenterology; 1976 Jun; 70(6):1007-13. PubMed ID: 1269860 [TBL] [Abstract][Full Text] [Related]
14. Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients. Parente F; Lazzaroni M; Sangaletti O; Baroni S; Bianchi Porro G Gut; 1985 Dec; 26(12):1327-32. PubMed ID: 3936754 [TBL] [Abstract][Full Text] [Related]
15. [Clinical value of determining pepsinogen I]. Griessen M; Male PJ; Infante F; Jodry H; Loizeau E Schweiz Med Wochenschr; 1984 Dec; 114(49):1849-51. PubMed ID: 6515384 [TBL] [Abstract][Full Text] [Related]
16. Serum group I pepsinogen (PG I) levels and their changes in the healing process of the ulcer in patients with and without unoperated recurrent ulcer. Nakanome C; Yamazaki H; Tanno N; Sasaki M; Sato W; Hanada M; Moriai N; Komatsu K Tohoku J Exp Med; 1984 Jun; 143(2):239-48. PubMed ID: 6474453 [TBL] [Abstract][Full Text] [Related]
17. Serum pepsinogen I in relation to some clinical features and complications of duodenal ulcer disease. Faraj FJ; Lule GN; Mwai JS East Afr Med J; 1989 Apr; 66(4):255-8. PubMed ID: 2743907 [TBL] [Abstract][Full Text] [Related]
18. High IgE serum levels and "peptic" ulcers: clinical and functional approach. De Lazzari F; Mancin O; Plebani M; Venturi C; Battaglia G; Vianello F; Galliani EA; Di Mario F; Naccarato R Ital J Gastroenterol; 1994; 26(1):7-11. PubMed ID: 7912969 [TBL] [Abstract][Full Text] [Related]
19. Duodenal ulcer is a multifactorial disorder--the role of pepsinogen I. Chang FY; Lai KH; Wang TF; Lee SD; Tsai YT S Afr Med J; 1993 Apr; 83(4):264-6. PubMed ID: 8316925 [TBL] [Abstract][Full Text] [Related]
20. Serum group I pepsinogens after consecutive stimulations with insulin and pentagastrin in unoperated duodenal ulcer patients and in duodenal ulcer patients after proximal gastric vagotomy. Paimela H; Lalla M; Räsänen V Scand J Gastroenterol; 1984 Jan; 19(1):52-5. PubMed ID: 6369521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]